{"transactions":[{"id":1361550,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":85973,"kind":"organization","name":"Vaccinex (Rochester), L.L.C.","position":2,"cik":"0001747866","reported_name":"Vaccinex (Rochester), L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-11-18T16:05:50.000Z","date":"2024-11-14","kind":"grant","planned":false,"acquired":true,"shares":46153,"price":3.25,"value":149997.25,"ownership":{"direct":false,"nature":"By Vaccinex (Rochester), L.L.C."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":297941,"source":{"system":"sec-edgar","filing":"0001062993-24-019265","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299324019265/form4.xml","form_type":"4"}},{"id":1401473,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":85973,"kind":"organization","name":"Vaccinex (Rochester), L.L.C.","position":2,"cik":"0001747866","reported_name":"Vaccinex (Rochester), L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (Right to Buy)","published_at":"2024-09-20T16:14:02.000Z","date":"2024-09-18","kind":"grant","planned":false,"acquired":true,"shares":170475,"price":0.125,"value":21309.375,"ownership":{"direct":false,"nature":"By Vaccinex (Rochester), L.L.C."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":170475,"derivative":{"exercise_price":5.636,"exercise_date":"2024-09-18","expiration_date":"2029-09-18","underlying":"Common Stock","underlying_shares":170475},"source":{"system":"sec-edgar","filing":"0001062993-24-016842","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299324016842/form4.xml","form_type":"4"}},{"id":1401472,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":85973,"kind":"organization","name":"Vaccinex (Rochester), L.L.C.","position":2,"cik":"0001747866","reported_name":"Vaccinex (Rochester), L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (Right to Buy)","published_at":"2024-09-20T16:14:02.000Z","date":"2024-09-18","kind":"exercise","planned":false,"acquired":false,"shares":35715,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Vaccinex (Rochester), L.L.C."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"This warrant was originally reported on Form 4 with an exercise price of $14.00. Pursuant to the Warrant Inducement Agreement, the exercise price of this warrant was adjusted to $5.636."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":5.636,"exercise_date":"2023-10-03","expiration_date":"2028-10-03","underlying":"Common Stock","underlying_shares":35715},"source":{"system":"sec-edgar","filing":"0001062993-24-016842","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299324016842/form4.xml","form_type":"4"}},{"id":1401471,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":85973,"kind":"organization","name":"Vaccinex (Rochester), L.L.C.","position":2,"cik":"0001747866","reported_name":"Vaccinex (Rochester), L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (Right to Buy)","published_at":"2024-09-20T16:14:02.000Z","date":"2024-09-18","kind":"exercise","planned":false,"acquired":false,"shares":9768,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Vaccinex (Rochester), L.L.C."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"This warrant was originally reported on Form 4 with an exercise price of $32.76. Pursuant to the Warrant Inducement Agreement, the exercise price of this warrant was adjusted to $5.636."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":5.636,"exercise_date":"2023-11-02","expiration_date":"2028-11-02","underlying":"Common Stock","underlying_shares":9768},"source":{"system":"sec-edgar","filing":"0001062993-24-016842","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299324016842/form4.xml","form_type":"4"}},{"id":1401470,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":85973,"kind":"organization","name":"Vaccinex (Rochester), L.L.C.","position":2,"cik":"0001747866","reported_name":"Vaccinex (Rochester), L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (Right to Buy)","published_at":"2024-09-20T16:14:02.000Z","date":"2024-09-18","kind":"exercise","planned":false,"acquired":false,"shares":29557,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Vaccinex (Rochester), L.L.C."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"This warrant was originally reported on Form 4 with an exercise price of $14.00. Pursuant to the Warrant Inducement Agreement, the exercise price of this warrant was adjusted to $5.636."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":5.636,"exercise_date":"2024-02-08","expiration_date":"2029-02-08","underlying":"Common Stock","underlying_shares":29557},"source":{"system":"sec-edgar","filing":"0001062993-24-016842","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299324016842/form4.xml","form_type":"4"}},{"id":1401469,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":85973,"kind":"organization","name":"Vaccinex (Rochester), L.L.C.","position":2,"cik":"0001747866","reported_name":"Vaccinex (Rochester), L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (Right to Buy)","published_at":"2024-09-20T16:14:02.000Z","date":"2024-09-18","kind":"exercise","planned":false,"acquired":false,"shares":38610,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Vaccinex (Rochester), L.L.C."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"This warrant was originally reported on Form 4 with an exercise price of $7.64. Pursuant to a warrant inducement agreement by and between the issuer and Vaccinex (Rochester) L.L.C. dated September 17, 2024 (the \"Warrant Inducement Agreement\"), the exercise price of this warrant was adjusted to $5.636."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":5.636,"exercise_date":"2024-03-28","expiration_date":"2029-03-28","underlying":"Common Stock","underlying_shares":38610},"source":{"system":"sec-edgar","filing":"0001062993-24-016842","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299324016842/form4.xml","form_type":"4"}},{"id":1401468,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":85973,"kind":"organization","name":"Vaccinex (Rochester), L.L.C.","position":2,"cik":"0001747866","reported_name":"Vaccinex (Rochester), L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-09-20T16:14:02.000Z","date":"2024-09-18","kind":"exercise","planned":false,"acquired":true,"shares":35715,"price":5.636,"value":201289.74,"ownership":{"direct":false,"nature":"By Vaccinex (Rochester), L.L.C."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This warrant was originally reported on Form 4 with an exercise price of $14.00. Pursuant to the Warrant Inducement Agreement, the exercise price of this warrant was adjusted to $5.636."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":251788,"source":{"system":"sec-edgar","filing":"0001062993-24-016842","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299324016842/form4.xml","form_type":"4"}},{"id":1401467,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":85973,"kind":"organization","name":"Vaccinex (Rochester), L.L.C.","position":2,"cik":"0001747866","reported_name":"Vaccinex (Rochester), L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-09-20T16:14:02.000Z","date":"2024-09-18","kind":"exercise","planned":false,"acquired":true,"shares":9768,"price":5.636,"value":55052.448,"ownership":{"direct":false,"nature":"By Vaccinex (Rochester), L.L.C."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This warrant was originally reported on Form 4 with an exercise price of $32.76. Pursuant to the Warrant Inducement Agreement, the exercise price of this warrant was adjusted to $5.636."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":216073,"source":{"system":"sec-edgar","filing":"0001062993-24-016842","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299324016842/form4.xml","form_type":"4"}},{"id":1401466,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":85973,"kind":"organization","name":"Vaccinex (Rochester), L.L.C.","position":2,"cik":"0001747866","reported_name":"Vaccinex (Rochester), L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-09-20T16:14:02.000Z","date":"2024-09-18","kind":"exercise","planned":false,"acquired":true,"shares":29557,"price":5.636,"value":166583.252,"ownership":{"direct":false,"nature":"By Vaccinex (Rochester), L.L.C."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This warrant was originally reported on Form 4 with an exercise price of $14.00. Pursuant to the Warrant Inducement Agreement, the exercise price of this warrant was adjusted to $5.636."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":206305,"source":{"system":"sec-edgar","filing":"0001062993-24-016842","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299324016842/form4.xml","form_type":"4"}},{"id":1401465,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":85973,"kind":"organization","name":"Vaccinex (Rochester), L.L.C.","position":2,"cik":"0001747866","reported_name":"Vaccinex (Rochester), L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-09-20T16:14:02.000Z","date":"2024-09-18","kind":"exercise","planned":false,"acquired":true,"shares":38610,"price":5.636,"value":217605.96,"ownership":{"direct":false,"nature":"By Vaccinex (Rochester), L.L.C."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This warrant was originally reported on Form 4 with an exercise price of $7.64. Pursuant to a warrant inducement agreement by and between the issuer and Vaccinex (Rochester) L.L.C. dated September 17, 2024 (the \"Warrant Inducement Agreement\"), the exercise price of this warrant was adjusted to $5.636."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":176748,"source":{"system":"sec-edgar","filing":"0001062993-24-016842","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299324016842/form4.xml","form_type":"4"}},{"id":1517183,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-14T16:34:50.000Z","date":"2024-03-21","kind":"grant","planned":false,"acquired":true,"shares":1877,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Due to an administrative error, the original Form 4 mistakenly listed the transaction date as March 20, 2024. The transaction actually occurred on March 21, 2024. Accordingly, the exercise price of the stock option is $8.21 per share, as opposed to the exercise price of $9.15 that was listed in the original Form 4."},{"field":"date","element":"transactionDate","label":"F1","text":"Due to an administrative error, the original Form 4 mistakenly listed the transaction date as March 20, 2024. The transaction actually occurred on March 21, 2024. Accordingly, the exercise price of the stock option is $8.21 per share, as opposed to the exercise price of $9.15 that was listed in the original Form 4."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the March 21, 2024 grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Due to an administrative error, the original Form 4 mistakenly listed the stock option expiration date as March 20, 2029. The expiration date is actually March 21, 2034."}],"balance_after":1877,"derivative":{"exercise_price":8.21,"expiration_date":"2034-03-21","underlying":"Common Stock","underlying_shares":1877},"source":{"system":"sec-edgar","filing":"0001062993-24-010185","document":"form4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299324010185/form4a.xml","form_type":"4/A","original_submission_date":"2024-03-22"}},{"id":1556035,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":85973,"kind":"organization","name":"Vaccinex (Rochester), L.L.C.","position":2,"cik":"0001747866","reported_name":"Vaccinex (Rochester), L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (Right to Buy)","published_at":"2024-04-01T20:54:14.000Z","date":"2024-03-28","kind":"grant","planned":false,"acquired":true,"shares":38610,"price":7.77,"value":299999.7,"ownership":{"direct":false,"nature":"By Vaccinex (Rochester), L.L.C."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":38610,"derivative":{"exercise_price":7.64,"exercise_date":"2024-03-28","expiration_date":"2029-03-28","underlying":"Common Stock","underlying_shares":38610},"source":{"system":"sec-edgar","filing":"0001062993-24-007661","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299324007661/form4.xml","form_type":"4"}},{"id":1556034,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":85973,"kind":"organization","name":"Vaccinex (Rochester), L.L.C.","position":2,"cik":"0001747866","reported_name":"Vaccinex (Rochester), L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-04-01T20:54:14.000Z","date":"2024-03-28","kind":"grant","planned":false,"acquired":true,"shares":38610,"price":7.77,"value":299999.7,"ownership":{"direct":false,"nature":"By Vaccinex (Rochester), L.L.C."},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":138138,"source":{"system":"sec-edgar","filing":"0001062993-24-007661","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299324007661/form4.xml","form_type":"4"}},{"id":1563199,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-22T16:31:19.000Z","date":"2024-03-20","kind":"grant","planned":false,"acquired":true,"shares":1877,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the March 20, 2024 grant date."}],"balance_after":1877,"derivative":{"exercise_price":9.15,"expiration_date":"2029-03-20","underlying":"Common Stock","underlying_shares":1877},"source":{"system":"sec-edgar","filing":"0001062993-24-006957","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299324006957/form4.xml","form_type":"4"}},{"id":1651374,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":85973,"kind":"organization","name":"Vaccinex (Rochester), L.L.C.","position":2,"cik":"0001747866","reported_name":"Vaccinex (Rochester), L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (Right to Buy)","published_at":"2024-02-09T16:34:03.000Z","date":"2024-02-08","kind":"grant","planned":false,"acquired":true,"shares":413793,"price":0.725,"value":299999.925,"ownership":{"direct":false,"nature":"By Vaccinex (Rochester), L.L.C."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":413793,"derivative":{"exercise_price":1,"exercise_date":"2024-02-08","expiration_date":"2029-02-08","underlying":"Common Stock","underlying_shares":413793},"source":{"system":"sec-edgar","filing":"0001062993-24-002770","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299324002770/form4.xml","form_type":"4"}},{"id":1651373,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":85973,"kind":"organization","name":"Vaccinex (Rochester), L.L.C.","position":2,"cik":"0001747866","reported_name":"Vaccinex (Rochester), L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-02-09T16:34:03.000Z","date":"2024-02-08","kind":"grant","planned":false,"acquired":true,"shares":413793,"price":0.725,"value":299999.925,"ownership":{"direct":false,"nature":"By Vaccinex (Rochester), L.L.C."},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":1393392,"source":{"system":"sec-edgar","filing":"0001062993-24-002770","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299324002770/form4.xml","form_type":"4"}},{"id":1749498,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":85973,"kind":"organization","name":"Vaccinex (Rochester), L.L.C.","position":2,"cik":"0001747866","reported_name":"Vaccinex (Rochester), L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (Right to Buy)","published_at":"2023-11-03T16:29:52.000Z","date":"2023-11-02","kind":"grant","planned":false,"acquired":true,"shares":136752,"price":0.125,"value":17094.0,"ownership":{"direct":false,"nature":"By Vaccinex (Rochester), L.L.C."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":136752,"derivative":{"exercise_price":2.34,"exercise_date":"2023-11-02","expiration_date":"2028-11-02","underlying":"Common Stock","underlying_shares":136752},"source":{"system":"sec-edgar","filing":"0001062993-23-020103","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299323020103/form4.xml","form_type":"4"}},{"id":1764280,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":85973,"kind":"organization","name":"Vaccinex (Rochester), L.L.C.","position":2,"cik":"0001747866","reported_name":"Vaccinex (Rochester), L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (Right to Buy)","published_at":"2023-10-05T16:31:37.000Z","date":"2023-10-03","kind":"purchase","planned":false,"acquired":true,"shares":500000,"price":1,"value":500000.0,"ownership":{"direct":false,"nature":"By Vaccinex (Rochester), L.L.C."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":500000,"derivative":{"exercise_price":1,"exercise_date":"2023-10-03","expiration_date":"2028-10-03","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001062993-23-019063","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299323019063/form4.xml","form_type":"4"}},{"id":1764279,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":85973,"kind":"organization","name":"Vaccinex (Rochester), L.L.C.","position":2,"cik":"0001747866","reported_name":"Vaccinex (Rochester), L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-10-05T16:31:37.000Z","date":"2023-10-04","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":0.973,"value":4865.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.9501 to $0.9898, inclusive. Mr. Zauderer undertakes to provide Vaccinex, Inc., any security holder of Vaccinex, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":22116,"source":{"system":"sec-edgar","filing":"0001062993-23-019063","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299323019063/form4.xml","form_type":"4"}},{"id":1764278,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":85973,"kind":"organization","name":"Vaccinex (Rochester), L.L.C.","position":2,"cik":"0001747866","reported_name":"Vaccinex (Rochester), L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-10-05T16:31:37.000Z","date":"2023-10-03","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":0.93,"value":4650.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.9265 to $0.9399, inclusive. Mr. Zauderer undertakes to provide Vaccinex, Inc., any security holder of Vaccinex, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":17116,"source":{"system":"sec-edgar","filing":"0001062993-23-019063","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299323019063/form4.xml","form_type":"4"}},{"id":1764277,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":85973,"kind":"organization","name":"Vaccinex (Rochester), L.L.C.","position":2,"cik":"0001747866","reported_name":"Vaccinex (Rochester), L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-10-05T16:31:37.000Z","date":"2023-10-03","kind":"purchase","planned":false,"acquired":true,"shares":500000,"price":1,"value":500000.0,"ownership":{"direct":false,"nature":"By Vaccinex (Rochester), L.L.C."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":979599,"source":{"system":"sec-edgar","filing":"0001062993-23-019063","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299323019063/form4.xml","form_type":"4"}},{"id":1773848,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-09-25T16:12:22.000Z","date":"2023-09-22","kind":"grant","planned":false,"acquired":true,"shares":2051282,"price":0.156,"value":319999.992,"ownership":{"direct":false,"nature":"By Vaccinex (Rochester), L.L.C."},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":7193973,"source":{"system":"sec-edgar","filing":"0001062993-23-018438","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299323018438/form4.xml","form_type":"4"}},{"id":1932061,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-03T16:31:57.000Z","date":"2023-03-31","kind":"grant","planned":false,"acquired":true,"shares":56000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the March 31, 2023 grant date."}],"balance_after":56000,"derivative":{"exercise_price":0.4395,"expiration_date":"2028-03-30","underlying":"Common Stock","underlying_shares":56000},"source":{"system":"sec-edgar","filing":"0001062993-23-008320","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299323008320/form4.xml","form_type":"4"}},{"id":1932060,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-04-03T16:31:57.000Z","date":"2023-03-31","kind":"grant","planned":false,"acquired":true,"shares":731707,"price":0.41,"value":299999.87,"ownership":{"direct":false,"nature":"By Vaccinex (Rochester), L.L.C."},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":5142691,"source":{"system":"sec-edgar","filing":"0001062993-23-008320","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299323008320/form4.xml","form_type":"4"}},{"id":2093141,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-12-07T16:30:51.000Z","date":"2022-12-06","kind":"other","acquired":true,"shares":3988,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":181736,"source":{"system":"sec-edgar","filing":"0001062993-22-023491","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299322023491/form4.xml","form_type":"4"}},{"id":2103392,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-11-28T16:35:57.000Z","date":"2022-11-23","kind":"grant","acquired":true,"shares":1511430,"price":0.5293,"value":799999.899,"ownership":{"direct":false,"nature":"By Vaccinex (Rochester), L.L.C."},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":4410984,"source":{"system":"sec-edgar","filing":"0001062993-22-022815","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299322022815/form4.xml","form_type":"4"}},{"id":2307639,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-04-04T16:34:54.000Z","date":"2022-04-01","kind":"grant","acquired":true,"shares":28000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the April 1, 2022 grant date."}],"balance_after":28000,"derivative":{"exercise_price":1.29,"expiration_date":"2032-04-01","underlying":"Common Stock","underlying_shares":28000},"source":{"system":"sec-edgar","filing":"0001062993-22-009448","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299322009448/form4.xml","form_type":"4"}},{"id":2420943,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-01-31T16:23:00.000Z","date":"2022-01-27","kind":"purchase","acquired":true,"shares":1801801,"price":1.11,"value":1999999.11,"ownership":{"direct":false,"nature":"By Vaccinex (Rochester), L.L.C."},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":2899554,"source":{"system":"sec-edgar","filing":"0001062993-22-001866","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000106299322001866/form4.xml","form_type":"4"}},{"id":2760702,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-02T16:27:23.000Z","date":"2021-04-02","kind":"grant","acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the April 2, 2021 grant date."}],"balance_after":14000,"derivative":{"exercise_price":2.93,"expiration_date":"2031-04-02","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0000891839-21-000100","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000089183921000100/edgar.xml","form_type":"4"}},{"id":3245966,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-26T16:25:40.000Z","date":"2020-02-25","kind":"grant","acquired":true,"shares":28400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the February 25, 2020 grant date."}],"balance_after":28400,"derivative":{"exercise_price":6.68,"expiration_date":"2025-02-24","underlying":"Common Stock","underlying_shares":28400},"source":{"system":"sec-edgar","filing":"0000891839-20-000054","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000089183920000054/edgar.xml","form_type":"4"}},{"id":3301163,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-01-27T16:23:22.000Z","date":"2020-01-23","kind":"purchase","acquired":true,"shares":98231,"price":5.09,"value":499995.79,"ownership":{"direct":false,"nature":"By Vaccinex (Rochester), L.L.C."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":1097753,"source":{"system":"sec-edgar","filing":"0000891839-20-000032","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000089183920000032/edgar.xml","form_type":"4"}},{"id":3451890,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-07-31T16:31:08.000Z","date":"2019-07-30","kind":"purchase","acquired":true,"shares":183824,"price":4.08,"value":750001.92,"ownership":{"direct":false,"nature":"By Vaccinex (Rochester), L.L.C."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Dr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":999522,"source":{"system":"sec-edgar","filing":"0000891839-19-000143","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000089183919000143/edgar.xml","form_type":"4"}},{"id":3586066,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-03-19T17:04:22.000Z","date":"2019-03-15","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the March 15, 2019 grant date."}],"balance_after":20000,"derivative":{"exercise_price":4.29,"expiration_date":"2024-03-14","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000891839-19-000052","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000089183919000052/edgar.xml","form_type":"4"}},{"id":3843148,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":85973,"kind":"organization","name":"Vaccinex (Rochester), L.L.C.","position":2,"cik":"0001747866","reported_name":"Vaccinex (Rochester), L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series D Convertible Preferred Stock","published_at":"2018-08-15T16:49:31.000Z","date":"2018-08-13","kind":"exercise","acquired":false,"shares":8157067,"ownership":{"direct":false,"nature":"By Vaccinex (Rochester), L.L.C."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"The reported securities converted into shares of Common Stock on a 1-for-10 basis immediately prior to the consummation of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported securities converted into shares of Common Stock on a 1-for-10 basis immediately prior to the consummation of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The reported securities converted into shares of Common Stock on a 1-for-10 basis immediately prior to the consummation of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The reported securities converted into shares of Common Stock on a 1-for-10 basis immediately prior to the consummation of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":815698},"source":{"system":"sec-edgar","filing":"0001123292-18-000926","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000112329218000926/edgar.xml","form_type":"4"}},{"id":3843147,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":85973,"kind":"organization","name":"Vaccinex (Rochester), L.L.C.","position":2,"cik":"0001747866","reported_name":"Vaccinex (Rochester), L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Convertible Preferred Stock","published_at":"2018-08-15T16:49:31.000Z","date":"2018-08-13","kind":"exercise","acquired":false,"shares":581577,"ownership":{"direct":false,"nature":"By Jordan M. Zauderer Trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The reported securities converted into shares of Common Stock on a 0.1641-for-1 basis immediately prior to the consummation of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported securities converted into shares of Common Stock on a 0.1641-for-1 basis immediately prior to the consummation of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The reported securities converted into shares of Common Stock on a 0.1641-for-1 basis immediately prior to the consummation of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The reported securities converted into shares of Common Stock on a 0.1641-for-1 basis immediately prior to the consummation of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Maurice Zauderer exercises voting control over shares held by this trust and disclaims beneficial ownership over these shares except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":95448},"source":{"system":"sec-edgar","filing":"0001123292-18-000926","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000112329218000926/edgar.xml","form_type":"4"}},{"id":3843146,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":85973,"kind":"organization","name":"Vaccinex (Rochester), L.L.C.","position":2,"cik":"0001747866","reported_name":"Vaccinex (Rochester), L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Convertible Preferred Stock","published_at":"2018-08-15T16:49:31.000Z","date":"2018-08-13","kind":"exercise","acquired":false,"shares":581577,"ownership":{"direct":false,"nature":"By Jeremy C. Zauderer Trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The reported securities converted into shares of Common Stock on a 0.1641-for-1 basis immediately prior to the consummation of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported securities converted into shares of Common Stock on a 0.1641-for-1 basis immediately prior to the consummation of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The reported securities converted into shares of Common Stock on a 0.1641-for-1 basis immediately prior to the consummation of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The reported securities converted into shares of Common Stock on a 0.1641-for-1 basis immediately prior to the consummation of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Maurice Zauderer exercises voting control over shares held by this trust and disclaims beneficial ownership over these shares except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":95448},"source":{"system":"sec-edgar","filing":"0001123292-18-000926","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000112329218000926/edgar.xml","form_type":"4"}},{"id":3843145,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":85973,"kind":"organization","name":"Vaccinex (Rochester), L.L.C.","position":2,"cik":"0001747866","reported_name":"Vaccinex (Rochester), L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Convertible Preferred Stock","published_at":"2018-08-15T16:49:31.000Z","date":"2018-08-13","kind":"exercise","acquired":false,"shares":569993,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The reported securities converted into shares of Common Stock on a 0.1641-for-1 basis immediately prior to the consummation of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported securities converted into shares of Common Stock on a 0.1641-for-1 basis immediately prior to the consummation of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The reported securities converted into shares of Common Stock on a 0.1641-for-1 basis immediately prior to the consummation of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The reported securities converted into shares of Common Stock on a 0.1641-for-1 basis immediately prior to the consummation of the Issuer's initial public offering."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":93547},"source":{"system":"sec-edgar","filing":"0001123292-18-000926","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000112329218000926/edgar.xml","form_type":"4"}},{"id":3843144,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":85973,"kind":"organization","name":"Vaccinex (Rochester), L.L.C.","position":2,"cik":"0001747866","reported_name":"Vaccinex (Rochester), L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-08-15T16:49:31.000Z","date":"2018-08-13","kind":"exercise","acquired":true,"shares":815698,"ownership":{"direct":false,"nature":"By Vaccinex (Rochester), L.L.C."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported securities converted into shares of Common Stock on a 1-for-10 basis immediately prior to the consummation of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Zauderer is the president and a majority owner of Vaccinex (Rochester), L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":815698,"source":{"system":"sec-edgar","filing":"0001123292-18-000926","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000112329218000926/edgar.xml","form_type":"4"}},{"id":3843143,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":85973,"kind":"organization","name":"Vaccinex (Rochester), L.L.C.","position":2,"cik":"0001747866","reported_name":"Vaccinex (Rochester), L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-08-15T16:49:31.000Z","date":"2018-08-13","kind":"exercise","acquired":true,"shares":95448,"ownership":{"direct":false,"nature":"By Jordan M. Zauderer Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported securities converted into shares of Common Stock on a 0.1641-for-1 basis immediately prior to the consummation of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Maurice Zauderer exercises voting control over shares held by this trust and disclaims beneficial ownership over these shares except to the extent of his pecuniary interest therein."}],"balance_after":212161,"source":{"system":"sec-edgar","filing":"0001123292-18-000926","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000112329218000926/edgar.xml","form_type":"4"}},{"id":3843142,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":85973,"kind":"organization","name":"Vaccinex (Rochester), L.L.C.","position":2,"cik":"0001747866","reported_name":"Vaccinex (Rochester), L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-08-15T16:49:31.000Z","date":"2018-08-13","kind":"exercise","acquired":true,"shares":95448,"ownership":{"direct":false,"nature":"By Jeremy C. Zauderer Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported securities converted into shares of Common Stock on a 0.1641-for-1 basis immediately prior to the consummation of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Maurice Zauderer exercises voting control over shares held by this trust and disclaims beneficial ownership over these shares except to the extent of his pecuniary interest therein."}],"balance_after":213209,"source":{"system":"sec-edgar","filing":"0001123292-18-000926","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000112329218000926/edgar.xml","form_type":"4"}},{"id":3843141,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":85972,"kind":"person","name":"Zauderer Maurice","position":1,"cik":"0001747753","reported_name":"Zauderer Maurice","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}},{"id":85973,"kind":"organization","name":"Vaccinex (Rochester), L.L.C.","position":2,"cik":"0001747866","reported_name":"Vaccinex (Rochester), L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-08-15T16:49:31.000Z","date":"2018-08-13","kind":"exercise","acquired":true,"shares":93547,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported securities converted into shares of Common Stock on a 0.1641-for-1 basis immediately prior to the consummation of the Issuer's initial public offering."}],"balance_after":177748,"source":{"system":"sec-edgar","filing":"0001123292-18-000926","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1205922/000112329218000926/edgar.xml","form_type":"4"}}]}